- Home
- TLSA vs SSSS Comparison
TLSA vs SSSS Comparison
Compare TLSA & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSA | SSSS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.8M | 223.3M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSA | SSSS |
|---|---|---|
| Price | $1.73 | $9.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.13 |
| AVG Volume (30 Days) | ★ 243.2K | 215.7K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | N/A | ★ 10.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.61 |
| Revenue | N/A | ★ $2,354,933.00 |
| Revenue This Year | N/A | $7,183.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $4.21 |
| 52 Week High | $2.60 | $10.34 |
Technical Indicators
Market Signals| Indicator | TLSA | SSSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 50.29 |
| Support Level | $1.66 | $9.31 |
| Resistance Level | $1.90 | $9.73 |
| Average True Range (ATR) | 0.15 | 0.36 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 49.46 | 64.73 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.